Search - tctmd.com

Displaying 281 - 300 of 754

Sort: Relevancy | Date

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Daily News

Clopidogrel Only Needed for 3 Months After ASD Closure: CANOA Analysis

Caitlin E. Cox

September 23, 2020

News Daily News

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Michael O'Riordan

September 18, 2020

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

News Conference News ESC 2020

More Bleeding, Death With Ticagrelor Over Clopidogrel in Elderly Post-MI Patients: SWEDEHEART

Yael L. Maxwell

September 08, 2020

News Conference News ESC 2020

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Caitlin E. Cox

September 03, 2020

News Conference News ESC 2020

Trimetazidine Safe but Not Protective Long-term After PCI

Caitlin E. Cox

August 30, 2020

News Daily News

Early Revascularization in NSTEMI Linked to Lower Mortality: AHRQ Analysis

Michael O'Riordan

August 20, 2020

News Daily News

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

L.A. McKeown

August 10, 2020

News Daily News

Reduced-Dose Prasugrel Works Well in Older, Low-Weight ACS Patients

Todd Neale

July 21, 2020

News Daily News

Short DAPT Reduces Bleeding With No Increase in MACE: Meta-analysis

Yael L. Maxwell

June 30, 2020

News Conference News EuroPCR 2020

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

Michael O'Riordan

June 26, 2020

News Conference News TVT 2020

Antithrombotics After PFO Closure: Much to Discuss, Little Data to Inform

Yael L. Maxwell

June 26, 2020

News Daily News

Most Stable Angina Patients Not Taking First-line Meds

Shelley Wood

June 18, 2020

News Daily News

TICONC: Ticagrelor May Cut Tumor-Induced Platelet Aggregation in Cancer Patients

L.A. McKeown

June 17, 2020

News Daily News

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

Michael O'Riordan

June 08, 2020

News Daily News

Injectable P2Y12 Inhibitor Selatogrel Shows Promise in Acute MI

Yael L. Maxwell

June 03, 2020

News Daily News

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

Yael L. Maxwell

May 21, 2020

News Daily News

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

Yael L. Maxwell

May 15, 2020

News Daily News

FOURIER Surveys Reassure About Cognitive Safety of Evolocumab

Todd Neale

May 06, 2020

Advertisement

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Clopidogrel Only Needed for 3 Months After ASD Closure: CANOA Analysis

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

More Bleeding, Death With Ticagrelor Over Clopidogrel in Elderly Post-MI Patients: SWEDEHEART

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Trimetazidine Safe but Not Protective Long-term After PCI

Early Revascularization in NSTEMI Linked to Lower Mortality: AHRQ Analysis

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

Reduced-Dose Prasugrel Works Well in Older, Low-Weight ACS Patients

Short DAPT Reduces Bleeding With No Increase in MACE: Meta-analysis

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

Antithrombotics After PFO Closure: Much to Discuss, Little Data to Inform

Most Stable Angina Patients Not Taking First-line Meds

TICONC: Ticagrelor May Cut Tumor-Induced Platelet Aggregation in Cancer Patients

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

Injectable P2Y12 Inhibitor Selatogrel Shows Promise in Acute MI

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

FOURIER Surveys Reassure About Cognitive Safety of Evolocumab

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content